Submission of Press Release for the Financial Results for the quarter and nine months ended December 31, 2025 in machine readable format.
ANTHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Anthem Biosciences has submitted its press release for the financial results of the quarter and nine months ended December 31, 2025 to the stock exchanges in a machine-readable format. This is a procedural/regulatory filing that accompanies the company's quarterly earnings announcement. The filing itself does not contain the actual financial numbers — those would be detailed in the attached press release and results document. Investors should look at the full earnings release for revenue, profit, margins, and segment details.
This filing has no direct price impact on its own; it simply ensures the quarterly results are available in a format required by the exchanges. Watch the actual earnings figures in the press release to gauge business performance.